FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to composite nanostructures applicable for photodynamic diagnosis of malignant tumours. The declared nanostructures represent gold-silver nanocells coated by silicone dioxide formed by tetraethylortosilicate hydrolysis in an alcohol medium The silicone dioxide coating surface is functionalised by itterbium 2,4-dimethoxyhematoporfirine.
EFFECT: preparing the composite nanoparticles combining plasma resonance within biotissue transparency (760-1000 nm), fluorescence in visible and near IR spectrum, photogeneration of singlet oxygen, increased collection in new growths.
7 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING COMPOSITE NANOSTRUCTURES: SILICON DIOXIDE - SILVER | 2017 |
|
RU2643697C1 |
NANOCOMPOSITES FOR MAGNETOLUMINESCENT THERANOSTICS OF NEOPLASMS | 2021 |
|
RU2766513C1 |
PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 |
|
RU2617045C1 |
METHOD OF MAKING POWDER PREPARATION OF NOBLE METAL NANOPARTICLES | 2011 |
|
RU2489231C1 |
NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 |
|
RU2578976C2 |
METHOD OF SELECTIVE LASER PHOTOTHERMOLYSIS OF CANCER CELLS BY PLASMON RESONANCE NANOPARTICLES | 2015 |
|
RU2653801C1 |
METHOD FOR SELECTIVE DESTRUCTION OF MELANOMA | 2007 |
|
RU2347563C1 |
METHOD FOR HYBRID PLASMON-LUMINESCENT MARKERS PRODUCTION | 2015 |
|
RU2614245C1 |
METHOD OF LASER PHOTOTHERMOLYSIS OF CANCER CELLS | 2009 |
|
RU2424831C1 |
YTTERBIUM COMPLEX OF 2,4-DIMETHOXYHEMATOPORPHYRIN IX DIPOTASSIUM SALT AS FLUORESCENT TAG FOR EARLY CANCER DIAGNOSIS | 2009 |
|
RU2411243C1 |
Authors
Dates
2012-10-10—Published
2011-05-05—Filed